Cervical screening and management of cervical intraepithelial neoplasia in HIV-positive women

International Journal of STD and AIDS

Volumn 17, Issue 9, 2006, Pages 579-586

  Danso, Dennis ^a   Lyons, Fiona ^a   Bradbeer, Caroline ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

Cervical screening; CIN in HIV positive women; Management

Indexed keywords

FLUOROURACIL; TUMOR VACCINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CANCER GRADING; CANCER RISK; CLINICAL TRIAL; COLPOSCOPY; CRYOSURGERY; EXCISION; HEALTH CENTER; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HYSTERECTOMY; IMMUNE DEFICIENCY; INCIDENCE; LASER SURGERY; PAPANICOLAOU TEST; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; REVIEW; SCREENING; UTERINE CERVIX BIOPSY; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; UTERINE CERVIX DYSPLASIA; WART VIRUS;

ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CERVICAL INTRAEPITHELIAL NEOPLASIA; FEMALE; FLUOROURACIL; FOLLOW-UP STUDIES; FORECASTING; HIV INFECTIONS; HIV SEROPOSITIVITY; HUMANS; MASS SCREENING; PREVALENCE; UTERINE CERVICAL NEOPLASMS;

EID: 33748365029     PISSN: 09564624     EISSN: 09564624     Source Type: Journal    
DOI: 10.1258/095646206778113087     Document Type: Review

References (67)

1. Bradbeer C. Is infection with HIV a risk factor for cervical intraepithelial neoplasia? Lancet 1987;2:1277-8
2. From the Centers for Disease Control and Prevention. 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. JAMA 1993;269:729
3. International Federation of Gynecology and Obstetrics, Annual report, 1986
4. Frisch AL, Biggar RJ, Goedert JJ. Human papilloma virus-associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome. J Natl Cancer Inst 2000;92:1500
5. Fruchter RG, Maiman M, Arrastia CD, et al. Is HIV infection a risk factor for advanced cervical cancer? J Acquir Immune Defic Syndr Hum Retrovirol 1998;18:241-5
6. Maiman M, Fruchter RG, Serur E, et al. Recurrent cervical intraepithelial neoplasia in human immunodeficiency virus-seropositive women. Obstet Gynecol 1993;82:170-4
7. Schwartz LB, Carcangiu ML, Bradman L, Schwartz PE. Rapidly progressive squamous cell carcinoma of the cervix coexisting with human immunodeficiency virus infection: clinical opinion. Gynecol Oncol 1991;41:255-8
8. Rellihan MA, Dooley DP, Burke TW, et al. Rapidly progressing cervical cancer in a patient with human immunodeficiency virus infection. Gynecol Oncol 1990;36:435-438
9. Fruchter RG, Palefsky J, Reister KA, et al. Abnormal cervical cytology in HIV-infected women [Abstract 6]. J Acquir Immune Defic Syndr Hum Retrovirol 97;14:A17
10. Massad LS, Riester KA, Anastos KM, et al. Prevalence and predictors of squamous cell abnormalities in Papanicolaou smears from women infected with HIV-1. Women's Interagency HIV Study Group. J Acquir Immune Defic Syndr Hum retrovirol 1999;21:33-41
11. Delmas M-C, Agarossi A, Bergeron C, et al. Incidence of squamous intraepithelial lesions in HIV women [Abstract 22306]. 12th World AIDS Conference, Geneva, Switzerland, 1998
12. Mandelblatt JS, Fahs M, Garibaldi K, et al. Association between HIV infection and cervical neoplasia: Implications for clinical care of women at risk for both conditions. AIDS 1992;6:173-8
13. Vermund SH, Kelley KF, Klein RS, Feingold AR, Schreiber K. High risk of HPV infection and cervical squamous intraepithelial lesions among women with human immunodeficiency virus. Am J Obstet Gynecol 1991;165:392-400
14. Ellerbrock TV, Chiasson MA, Bush TJ, et al. Incidence of cervical squamous intraepithelial lesions in HIV-infected women. JAMA 2000;283:1031-7
15. Six C, Heard I, Bergeron C, et al. Comparative prevalence, incidence and short term prognosis of cervical squamous intraepithelial lesions amongst HIV-positive and HIV-negative women. AIDS 1998;12:1047-56
16. Holcomb K, Maiman M, DiMaio T, Gates J. Rapid progression to invasive cervical cancer in a woman infected with the human immunodeficiency virus. Obstet Gynecol 1998;91:848
17. Belafsky P, Clark RA, Kissinger P, Torres J. Natural history of low-grade squamous intraepithelial lesions in women infected with human immunodeficiency virus. J Acquir Immune Defic Syndr Hum Retrovirol 1996;11:511
18. Sun XW, Kuhn L, Ellerbrock TV, et al. Human papillomavirus infection in women infected with the human immunodeficiency virus. N Engl J Med 1997;337:1343-9
19. Vernon SD, Reeves WC, Clancy KA, et al. A longitudinal study of human papillomavirus DNA detection in human immunodeficiency virus type 1-seropositive and -seronegative women. J Infect Dis 1994;169:1108-12
20. Palefsky JM, Minkoff H, Kalish LA, et al. Cervicovaginal human papilloma virus infection in human immunodeficiency virus-1 (HIV)-positive and high-risk HIV-negative women. J Natl Cancer Inst 1999;91:226-36
21. Minkoff H, Feldman J, DeHovitz J, et al. A longitudinal study of human papillomavirus carriage in human immunodeficiency virus-infected and human immunodeficiency virus-uninfected women. Am J Obstet Gynecol 1998;178:982-6
22. Lillo FB, Lodini S, Ferrari D, et al. Determination of human papillomavirus (HPV) load and type in high-grade cervical lesions surgically resected from HIV-infected women during follow-up of HPV infection. Clin Infect Dis 2005;40:451-7. Epub 2005
23. Moscicki AB, Ellenberg JH, Vermund SH, et al. Prevalence of and risks for cervical human papillomavirus infection and squamous intraepithelial lesions in adolescent girls. Arch Pediatr Adolesc Med 2000;154:127-34
24. Langley CL, Benga-DEE, Critchlow CW, et al. HIV-1, HIV-2, HPV and cervical neoplasia in high-risk African women. AIDS 1996;10:413-17
25. Klein SA, Dobmeyer JM, Dobmeyer TS, et al. Demonstration of the Th1 to Th2 shift during the course of HIV-1 infection using cytoplasmic cytokine detection on single cell level by flow cytometry. AIDS 1997;11:1111-18
26. Vernon SD, Hart CE, Reeves WC, Icenogle JP. The HIV-1 tat protein enhances E2-dependent human papillomavirus 16 transcription. Virus Res 1993;27:133-45
27. Tornesello ML, Buonaguro FM, Beth-Giraldo E, et al. Human immunodeficiency virus type 1 tat gene enhances human papillomavirus early gene expression. Intervirology 1993;36:57-64
28. Delmas MC, Larsen C, Van Benthem B, et al. Cervical squamous intraepithelial lesions in HIV-infected women: prevalence, incidence and regression. European Study Group on Natural History of HIV Infection in Women. AIDS 2000;14:1775
29. Heard I, Schmitz V, Costagliola D, et al. Early regression of cervical lesions in HIV-seropositive women receiving highly active antiretroviral therapy. AIDS 1998;12:1459
30. Robinson WR, Hamilton CA, Michaels SH, Kissinger P. Effects of excisional therapy and highly active antiretroviral therapy on cervical intraepithelial neoplasia in women infected with human immunodeficiency virus. Am J Obstet Gynecol 2001;184:538
31. Heard I, Tassie JM, Kazatchkine MD, Orth G. Highly active antiretroviral therapy enhances regression of cervical intraepithelial neoplasia in HIV-seropositive women. AIDS 2002;16:1799
32. Minkoff H, Ahdieh L, Massad LS, et al. The effect of highly active antiretroviral therapy on cervical cytologic changes associated with oncogenic HPV among HIV-infected women. AIDS 2001;15:2157
33. Orlando G, Fasolo MM, Sciavini M, et al. Role of highly active antiretroviral therapy in human papillomavirus-induced genital dysplasia in HIV-1 infected patients. AIDS 1999;13:424
34. Ahdieh-Grant L, Li R, Levine AM, et al. Highly active antiretroviral therapy and cervical squamous intraepithelial lesions in human immunodeficiency virus-positive women. J Natl Cancer Inst 2004;96:1070
35. Sasieni PD. Estimating the efficacy of screening by auditing smear histories of women with and without cervical cancer. The National Coordinating Network for Cervical Screening Working Group. Br J Cancer 1996;73:1001-5
36. Peto J, Gilham C, Fletcher O, et al. The cervical cancer epidemic that screening has presented in the UK. Lancet 2004;364:249-56
37. Fink MJ, Fruchter RG, Maiman M, et al. The adequacy of cytology and colposcopy in diagnosing cervical neoplasia in HIV-seropositive women. Gynecol Oncol 1994;55:133-7
38. Maiman M, Tarricone N, Vieira J, et al. Colposcopic evaluation of human immunodeficiency virus seropositive women. Obstet Gynecol 1991;78:84-8
39. Wright TC, Ellerbrock TV, Chiasson MA, et al. Cervical intraepithelial neoplasia in women infected with human immunodeficiency virus: prevalence, risk factors, and validity of Papanicolaou smears. Obstet Gynecol 1994;84:591-97
40. Heard I, Bergeron C, Jeannel D, et al. Papanicolaou smears in Human Immunodeficiency Virus-seropositive women during follow-up. Obstet Gynecol 1995;86:749-53
41. Mitchell MF, Tortolaro-Luna G, Cook E, et al. A randomised clinical trial of cryotherapy, laser vaporisation and loop electrosurgical excision for the treatment of squamous intraepithelial lesions of the cervix. Obstet Gynecol 1998;92:737-44
42. CDC. Guidelines for the treatment of sexually transmitted diseases. MMWR 1998;47:01
43. UN National Health Service Cervical Screening Programme Guideline, April 2004;448
44. Palefsky JM. Human papillomavirus-associated anogenital neoplasia and other solid tumours in human immunodeficiency virus-infected individuals. Curr Opin Oncol 1991;3:881-5
45. Wright TC, Moscarelli RD, Dole P, et al. Significance of mild cytologic atypia in women infected with human immunodeficiency virus. Obstet Gynecol 1996;87:515-9
46. Cejtin HE, Komaroff E, Massad LS, et al. Adherence to colposcopy among women with HIV infection. J Acquir Immune Defic Syndr 1999;22:247-52
47. Murphy M, Pomeroy L, Tynan M, et al. Cervical cytological screening in HIV-infected women in Dublin - a six year review. Int J STD AIDS 1995;6:262-6
48. Goldie SJ, Weinstein MC, Kuntz KM, et al. The costs, clinical benefits, and cost-effectiveness of screening for cervical cancer in HIV-infected women. Ann Intern Med 1999;130:97-107
49. Goldie SJ, Freedberg KA, Weinstein MC, et al. Costeffectiveness of human papillomavirus testing to augment cervical cancer screening in women infected with the human immunodeficiency virus. Am J Med 2001;111:140-9
50. Cohn JA, Gagnon S, Spence MR, et al. The role of human papillomavirus deoxyribonucleic acid assay and repeated cervical cytologic examination in the detection of cervical intraepithelial neoplasia among human immunodeficiency virus-infected women. Am J Obstet Gynecol 2001;184:322-30
51. Fruchter RG, Maiman M, Sedlis A, et al. Multiple recurrences of cervical intraepithelial neoplasia in women with the human immunodeficiency virus. Obstet Gynecol 1996;87:338-44
52. Burghardt E, Holzer E. Treatment of carcinoma in situ: evaluation of 1609 cases. Obstet Gynecol 1980;55:539-45
53. Wright Jr TC, Koulos J, Schnoll F, et al. Cervical intraepithelial neoplasia in women infected with the human immunodeficiency virus: outcome after loop electrosurgical excision. Gynecol Oncol 1994;55:253-8
54. Maiman M, Fruchter RG, Serur E, et al. Human immunodeficiency virus infection and cervical neoplasia. Gynecol Oncol 1990;38:377
55. Robinson WR, Tirpack JS. The predictive value of LEEP specimens with involved margins for residual dysplasia. Int J Gynecol Cancer 1996;6:140
56. Robinson WR, Lund Ed, Adams J. The predictive value of LEEP specimen margin status for residual/recurrent cervical intraepithelial neoplasia. Int J Gynecol Oncol 1998;8:109
57. Benedet JL, Miller DM, Nickerson KG. Results of conservative management of cervical intraepithelial neoplasia. Obstet Gynecol 1992;79:105-10
58. Krebs HB. Prophylactic topical 5-fluorouracil following treatment of human papillomavirus-associated lesions of the vulva and vagina. Obstet Gynecol 1986;68:837-41
59. Maiman M, Watts DH, Andersen J, et al. Vaginal 5-fluorouracil for high-grade cervical dysplasia in human immunodeficiency virus infection: a randomised trial. Obstet Gynecol 1999;94:954-61
60. Sillman FH, Sedlis A. Anogenital papillomavirus infection and neoplasia in immunodeficient women. Obstet Gynecol Clin North Am 1987;14:537-8
61. Maw RD. Treatment of external genital warts with 5% Imiquimod cream during pregnancy: a case report. Br J Obstet Gynacol 2004;111:1475
62. Garland SM. Imiquimod review. Curr Opin Infect Dis 2003;16:85-9
63. Campagne G, Roca M, Martinez A. Successful treatment of a high-grade intraepithelial neoplasia with Imiquimod, with vulvar pemphigus as a side effect. Eur J Obstet Gynecol Reprod Biol 2003;109:224-7
64. Sheets EE, Urban RG, Crum CP, et al. Immunotherapy of human cervical high-grade cervical intraepithelial neoplasia with microparticle-delivered human papillomavirus 16 E7 plasmid DNA. Am J Obstet Gynecol 2003;188:916-26
65. Brinkman JA, Caffrey AS, Muderspach LI, Roman LD, Kast WM. The impact of anti HPV vaccination on cervical cancer and HPV induced cervical lesions: consequences for clinical management. Eur J Gynaecol Oncol 2005;26:129-42
66. Maiman M, Fruchter RG, Guy L, et al. Human immunodeficiency virus infection and invasive cervical carcinoma. Cancer 1993;71:402-6
67. Shrivastava SK, Engineer R, Rajadhyaksha S, Dinshaw KA. HIV infection and invasive cervical cancers, treatment with radiation therapy: toxicity and outcome. Radiother Oncol 2005;74:31-5